FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2267885473> ?p ?o ?g. }

• W2267885473 abstract "6076 Background: Impressive outcomes have been achieved using multiagent neoadjuvant and concomitant chemotherapy combined with radiation in definitive treatment of head and neck cancer; these are associated with significant toxicities. The purpose of this study was to determine the efficacy and toxicities of single-agent weekly (CDDP) during curative-intent radiation therapy. Methods: 36 patients with AJCC Stage II (3%), Stage III (14%), Stage IV (83%) squamous cell carcinoma of the larynx, hypopharynx, oropharynx and oral cavity treated from 6/2000 to 11/2003 were retrospectively reviewed. Subjects received 72 Gy irradiation given either by hyperfractionation or IMRT technique with CDDP 30 mg/m 2 /wk throughout the radiation course. Cisplatin was held for Grade III/IV toxicities. The endpoints were best response, percentage of Grade III/IV toxicities, disease-free survival (DFS), overall survival (OS). Results: The median number of cycles of CDDP administered was 6. Grade III/IV toxicities: 11% of patients had anemia, 6% thrombocytopenia, 33% leukopenia, 0% renal failure, and 25% developed Grade III/IV mucositis; 1 patient (3%) died due to complications directly related to therapy. Responses to therapy included 72% CR, 17% PR, and 5% SD. Median follow-up for all patients was 19 months (34.5 months for living patients), DFS at 3 years (yrs.) was 59%, and OS at 3 yrs, was 40%. Nine patients died of disease up to 2.6 (median, 0.7) yrs. after treatment, while 11 died of intercurrent diseases up to 5.1 (median, 1.8) yrs. later. Fifteen are alive (2 with recurrence) at median 2.7 yrs. after treatment. Conclusion: Concomitant weekly CDDP with full-course radiation is feasible, tolerable, highly active, and comparable to more complex, costly and toxic regimens. Intercurrent disease was a significant contributor to mortality in our population. Our regimen is an attractive alternative to sequential chemoradiotherapy programs. No significant financial relationships to disclose." @default.
• W2267885473 created "2016-06-24" @default.
• W2267885473 creator A5008642709 @default.
• W2267885473 creator A5021501573 @default.
• W2267885473 creator A5023899503 @default.
• W2267885473 creator A5042970744 @default.
• W2267885473 creator A5070912963 @default.
• W2267885473 date "2007-06-20" @default.
• W2267885473 modified "2023-09-27" @default.
• W2267885473 title "Validation of weekly-dose cisplatin combined with radiation therapy in locally advanced head and neck cancer" @default.
• W2267885473 doi "https://doi.org/10.1200/jco.2007.25.18_suppl.6076" @default.
• W2267885473 hasPublicationYear "2007" @default.
• W2267885473 type Work @default.
• W2267885473 sameAs 2267885473 @default.
• W2267885473 citedByCount "1" @default.
• W2267885473 crossrefType "journal-article" @default.
• W2267885473 hasAuthorship W2267885473A5008642709 @default.
• W2267885473 hasAuthorship W2267885473A5021501573 @default.
• W2267885473 hasAuthorship W2267885473A5023899503 @default.
• W2267885473 hasAuthorship W2267885473A5042970744 @default.
• W2267885473 hasAuthorship W2267885473A5070912963 @default.
• W2267885473 hasConcept C121608353 @default.
• W2267885473 hasConcept C126322002 @default.
• W2267885473 hasConcept C141071460 @default.
• W2267885473 hasConcept C143998085 @default.
• W2267885473 hasConcept C2776530083 @default.
• W2267885473 hasConcept C2776694085 @default.
• W2267885473 hasConcept C2778239845 @default.
• W2267885473 hasConcept C2989005 @default.
• W2267885473 hasConcept C3018411727 @default.
• W2267885473 hasConcept C509974204 @default.
• W2267885473 hasConcept C71924100 @default.
• W2267885473 hasConceptScore W2267885473C121608353 @default.
• W2267885473 hasConceptScore W2267885473C126322002 @default.
• W2267885473 hasConceptScore W2267885473C141071460 @default.
• W2267885473 hasConceptScore W2267885473C143998085 @default.
• W2267885473 hasConceptScore W2267885473C2776530083 @default.
• W2267885473 hasConceptScore W2267885473C2776694085 @default.
• W2267885473 hasConceptScore W2267885473C2778239845 @default.
• W2267885473 hasConceptScore W2267885473C2989005 @default.
• W2267885473 hasConceptScore W2267885473C3018411727 @default.
• W2267885473 hasConceptScore W2267885473C509974204 @default.
• W2267885473 hasConceptScore W2267885473C71924100 @default.
• W2267885473 hasLocation W22678854731 @default.
• W2267885473 hasOpenAccess W2267885473 @default.
• W2267885473 hasPrimaryLocation W22678854731 @default.
• W2267885473 hasRelatedWork W1978232913 @default.
• W2267885473 hasRelatedWork W1984145246 @default.
• W2267885473 hasRelatedWork W2064900812 @default.
• W2267885473 hasRelatedWork W2133012517 @default.
• W2267885473 hasRelatedWork W2301171410 @default.
• W2267885473 hasRelatedWork W2329989716 @default.
• W2267885473 hasRelatedWork W2336726368 @default.
• W2267885473 hasRelatedWork W2396816698 @default.
• W2267885473 hasRelatedWork W2403669155 @default.
• W2267885473 hasRelatedWork W3016922835 @default.
• W2267885473 isParatext "false" @default.
• W2267885473 isRetracted "false" @default.
• W2267885473 magId "2267885473" @default.
• W2267885473 workType "article" @default.